3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with quinagolide in 2 studies
| Studies (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Trials (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Recent Studies (post-2010) (3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide) | Studies (quinagolide) | Trials (quinagolide) | Recent Studies (post-2010) (quinagolide) |
|---|---|---|---|---|---|
| 330 | 40 | 33 | 192 | 43 | 35 |
| Protein | Taxonomy | 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide (IC50) | quinagolide (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 4.1333 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 6.9 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 4.1333 | |
| D(2) dopamine receptor | Bos taurus (cattle) | 0.1086 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 6.9 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | 4.1333 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 4.1333 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 6.9 | |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 4.1333 | |
| D | Bos taurus (cattle) | 0.1086 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 4.6 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 4.1333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Herder, WW; Hofland, LJ; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Nobels, FR; Oei, HY; Reijs, AE | 1 |
| Acampa, W; Cerbone, G; Colao, A; Ferone, D; Lastoria, S; Lombardi, G; Merola, B; Salvatore, M; Varrella, P | 1 |
1 trial(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and quinagolide
| Article | Year |
|---|---|
Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.
Topics: Adenoma; Aminoquinolines; Benzamides; Biomarkers; Dopamine Agonists; Glycoprotein Hormones, alpha Subunit; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Iodine Radioisotopes; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Pyrrolidines; Tomography, Emission-Computed, Single-Photon | 1998 |
1 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and quinagolide
| Article | Year |
|---|---|
In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.
Topics: Adenoma; Adolescent; Adult; Aminoquinolines; Benzamides; Contrast Media; Dopamine Agonists; Dopamine Antagonists; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine D2; Thyrotropin; Tomography, Emission-Computed, Single-Photon | 1996 |